{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:28:36Z","timestamp":1784068116047,"version":"3.55.0"},"reference-count":137,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","award":["20K22885"],"award-info":[{"award-number":["20K22885"]}]},{"name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","award":["22K15696"],"award-info":[{"award-number":["22K15696"]}]},{"name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","award":["18K11658"],"award-info":[{"award-number":["18K11658"]}]},{"name":"Ministry of Education, Culture, Sports, Science, and Technology, Japan","award":["21K12256"],"award-info":[{"award-number":["21K12256"]}]},{"name":"Long-Range Research Initiative of the Japan Chemical Industry Association","award":["20K22885"],"award-info":[{"award-number":["20K22885"]}]},{"name":"Long-Range Research Initiative of the Japan Chemical Industry Association","award":["22K15696"],"award-info":[{"award-number":["22K15696"]}]},{"name":"Long-Range Research Initiative of the Japan Chemical Industry Association","award":["18K11658"],"award-info":[{"award-number":["18K11658"]}]},{"name":"Long-Range Research Initiative of the Japan Chemical Industry Association","award":["21K12256"],"award-info":[{"award-number":["21K12256"]}]},{"name":"POLA Chemical Industries, Inc.","award":["20K22885"],"award-info":[{"award-number":["20K22885"]}]},{"name":"POLA Chemical Industries, Inc.","award":["22K15696"],"award-info":[{"award-number":["22K15696"]}]},{"name":"POLA Chemical Industries, Inc.","award":["18K11658"],"award-info":[{"award-number":["18K11658"]}]},{"name":"POLA Chemical Industries, Inc.","award":["21K12256"],"award-info":[{"award-number":["21K12256"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Haptens are small molecules that only elicit an immune response when bound to proteins. Haptens initially bind to self-proteins and activate innate immune responses by complex mechanisms via inflammatory cytokines and damage-associated molecular patterns and the subsequent upregulation of costimulatory signals such as cluster of differentiation 86 (CD86) on dendritic cells. Subsequent interactions between CD86 and CD28 on T cells are critically important for properly activating naive T cells and inducing interleukin 2 production, leading to the establishment of adaptive immunity via effector and memory T cells. Accumulating evidence revealed the involvement of haptens in the development of various autoimmune-like diseases such as allergic, inflammatory, and autoimmune diseases including allergic contact dermatitis, atopy, asthma, food allergy, inflammatory bowel diseases, hemolytic anemia, liver injury, leukoderma, and even antitumor immunity. Therefore, the development of in vitro testing alternatives to evaluate in advance whether a substance might lead to the development of these diseases is highly desirable. This review summarizes and discusses recent advances in chemical- and drug-induced allergic, inflammatory, and autoimmune diseases via haptenation and the possible molecular underlying mechanisms, as well as in vitro testing alternatives to evaluate in advance whether a substance might cause the development of these diseases.<\/jats:p>","DOI":"10.3390\/biology12010123","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T01:30:26Z","timestamp":1673573426000},"page":"123","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Chemical- and Drug-Induced Allergic, Inflammatory, and Autoimmune Diseases Via Haptenation"],"prefix":"10.3390","volume":"12","author":[{"given":"Eri","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Katahira","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izuru","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruma","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuma","family":"Furusaka","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miu","family":"Yamagishi","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukito","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Miyakawa","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Yo","sequence":"additional","affiliation":[{"name":"POLA Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama-shi 244-0812, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiya","family":"Yamaji","sequence":"additional","affiliation":[{"name":"POLA Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama-shi 244-0812, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Toyoda","sequence":"additional","affiliation":[{"name":"POLA Chemical Industries, Inc., 560 Kashio-cho, Totsuka-ku, Yokohama-shi 244-0812, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2847-0341","authenticated-orcid":false,"given":"Takayuki","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Immunoregulation, Institute of Medical Science, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1084\/jem.64.4.625","article-title":"Studies on the Sensitization of Animals with Simple Chemical Compounds","volume":"64","author":"Landsteiner","year":"1936","journal-title":"J. Exp. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0536.2007.00944.x","article-title":"Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles","volume":"56","author":"Aptula","year":"2007","journal-title":"Contact Dermat."},{"key":"ref_3","unstructured":"Gell, P.G.H., and Coombs, R.R.A. (1963). The classification of allergic reactions underlying disease. Clinical Aspects of Immunology, Blackwell Science."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1398-9995.2009.02082.x","article-title":"Effector and regulatory mechanisms in allergic contact dermatitis","volume":"64","author":"Vocanson","year":"2009","journal-title":"Allergy"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"175265","DOI":"10.1155\/2014\/175265","article-title":"Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: Plausibility of mediating antitumor immunity","volume":"2014","author":"Erkes","year":"2014","journal-title":"J. Immunol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Esser, P.R., Wolfle, U., Durr, C., von Loewenich, F.D., Schempp, C.M., Freudenberg, M.A., Jakob, T., and Martin, S.F. (2012). Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041340"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1084\/jem.20070509","article-title":"Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity","volume":"205","author":"Martin","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ni.1919","article-title":"Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel","volume":"11","author":"Schmidt","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1084\/jem.20092489","article-title":"Lack of the purinergic receptor P2X(7) results in resistance to contact hypersensitivity","volume":"207","author":"Weber","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2741\/s332","article-title":"Pharmacologic efficacy in inflammatory bowel disease models","volume":"4","author":"Nagaoka","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/1346-8138.15835","article-title":"Rhododendrol-induced leukoderma update I: Clinical findings and treatment","volume":"48","author":"Matsunaga","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/1346-8138.15878","article-title":"Rhododendrol-induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism-based treatments in comparison with vitiligo","volume":"48","author":"Inoue","year":"2021","journal-title":"J. Dermatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"839682","DOI":"10.1155\/2011\/839682","article-title":"Haptenation: Chemical reactivity and protein binding","volume":"2011","author":"Chipinda","year":"2011","journal-title":"J. Allergy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1084\/jem.149.1.185","article-title":"Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes","volume":"149","author":"Hamaoka","year":"1979","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.4049\/jimmunol.132.3.1571","article-title":"Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression","volume":"132","author":"Fujiwara","year":"1984","journal-title":"J. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.2004.06.043","article-title":"Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine","volume":"22","author":"Berd","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-002-0266-6","article-title":"Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors","volume":"51","author":"Lu","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1398-9995.2011.02652.x","article-title":"Mechanisms of chemical-induced innate immunity in allergic contact dermatitis","volume":"66","author":"Martin","year":"2011","journal-title":"Allergy"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bcpt.12202","article-title":"In vitro approaches for detection of chemical sensitization","volume":"115","author":"Roggen","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/toxsci\/kfn199","article-title":"The respiratory local lymph node assay as a tool to study respiratory sensitizers","volume":"106","author":"Arts","year":"2008","journal-title":"Toxicol. Sci."},{"key":"ref_21","first-page":"545","article-title":"Differential cytokine production following chronic exposure of mice to chemical respiratory and contact allergens","volume":"86","author":"Dearman","year":"1995","journal-title":"Immunology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/taap.1999.8841","article-title":"Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4","volume":"162","author":"Vandebriel","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.taap.2012.02.009","article-title":"Identification of contact and respiratory sensitizers according to IL-4 receptor alpha expression and IL-2 production","volume":"260","author":"Goutet","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/toxsci\/kfs071","article-title":"Differential gene expression responses distinguish contact and respiratory sensitizers and nonsensitizing irritants in the local lymph node assay","volume":"126","author":"Adenuga","year":"2012","journal-title":"Toxicol. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tox.2009.04.057","article-title":"Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure","volume":"261","author":"Arts","year":"2009","journal-title":"Toxicology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0300-483X(02)00299-8","article-title":"Chemical respiratory allergy: Role of IgE antibody and relevance of route of exposure","volume":"181\u2013182","author":"Kimber","year":"2002","journal-title":"Toxicology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tox.2014.02.001","article-title":"Chemical respiratory allergy: Reverse engineering an adverse outcome pathway","volume":"318","author":"Kimber","year":"2014","journal-title":"Toxicology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jaci.2012.05.006","article-title":"Urinary levels of triclosan and parabens are associated with aeroallergen and food sensitization","volume":"130","author":"Savage","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2500\/aap.2014.35.3803","article-title":"The associations of triclosan and paraben exposure with allergen sensitization and wheeze in children","volume":"35","author":"Spanier","year":"2014","journal-title":"Allergy Asthma Proc."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/toxsci\/kfab055","article-title":"Critical Evaluation of Low-Molecular Weight Respiratory Sensitizers and Their Protein Reactivity Potential Toward Lysine Residues","volume":"182","author":"Krutz","year":"2021","journal-title":"Toxicol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/10408444.2021.2024142","article-title":"Identifying a reference list of respiratory sensitizers for the evaluation of novel approaches to study respiratory sensitization","volume":"51","author":"Sadekar","year":"2021","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/DER.0000000000000472","article-title":"Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?","volume":"30","author":"Kim","year":"2019","journal-title":"Dermatitis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12788\/cutis.0340","article-title":"Plant Dermatitis: More Than Just Poison Ivy","volume":"108","author":"Watchmaker","year":"2021","journal-title":"Cutis"},{"key":"ref_34","unstructured":"Lofgran, T., and Mahabal, G.D. (2022). Toxicodendron Toxicity. StatPearls, StatPearls."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40659-021-00357-z","article-title":"Allergens of the urushiol family promote mitochondrial dysfunction by inhibiting the electron transport at the level of cytochromes b and chemically modify cytochrome c(1)","volume":"54","author":"Pacheco","year":"2021","journal-title":"Biol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000024010","article-title":"CD8+ T cells are the effectors of the contact dermatitis induced by urushiol in mice and are regulated by CD4+ T cells","volume":"117","author":"Lopez","year":"1998","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1084\/jem.182.5.1281","article-title":"Antibodies to interleukin 12 abrogate established experimental colitis in mice","volume":"182","author":"Neurath","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Katsandegwaza, B., Horsnell, W., and Smith, K. (2022). Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169344"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Silva, I., Pinto, R., and Mateus, V. (2019). Preclinical Study in Vivo for New Pharmacological Approaches in Inflammatory Bowel Disease: A Systematic Review of Chronic Model of TNBS-Induced Colitis. J. Clin. Med., 8.","DOI":"10.3390\/jcm8101574"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Silva, I., Solas, J., Pinto, R., and Mateus, V. (2022). Chronic Experimental Model of TNBS-Induced Colitis to Study Inflammatory Bowel Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094739"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.188.10.1929","article-title":"Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4","volume":"188","author":"Boirivant","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1074-7613(02)00453-3","article-title":"Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells","volume":"17","author":"Heller","year":"2002","journal-title":"Immunity"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/gutjnl-2014-308337","article-title":"Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: Efficacy and safety from a phase IIa randomised multicentre study","volume":"64","author":"Reinisch","year":"2015","journal-title":"Gut"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gutjnl-2014-308004","article-title":"Tralokinumab for moderate-to-severe UC: A randomised, double-blind, placebo-controlled, phase IIa study","volume":"64","author":"Danese","year":"2015","journal-title":"Gut"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1523-1747.1998.00122.x","article-title":"Molecular features of penicillin allergy","volume":"110","author":"Weltzien","year":"1998","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/all.14355","article-title":"The complexity of T cell-mediated penicillin hypersensitivity reactions","volume":"76","author":"Goh","year":"2021","journal-title":"Allergy"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/14740338.5.1.31","article-title":"Allergic reactions to beta-lactams","volume":"5","author":"Antunez","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2009.1.73","article-title":"Drug-induced immune hemolytic anemia","volume":"8","author":"Garratty","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: The last 30 years of changes","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/voxs.12469","article-title":"Drug-induced immune haemolytic anemias","volume":"14","author":"Branch","year":"2019","journal-title":"ISBT Sci. Ser."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"876","DOI":"10.5858\/arpa.2014-0214-RA","article-title":"Drug-Induced Liver Injury","volume":"139","author":"Fisher","year":"2015","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"s104","DOI":"10.7861\/clinmedicine.16-6-s104","article-title":"Drug-induced liver injury","volume":"16","author":"Katarey","year":"2016","journal-title":"Clin. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1389200219666180523095355","article-title":"Models of Drug Induced Liver Injury (DILI)\u2014Current Issues and Future Perspectives","volume":"19","author":"Kuna","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_56","first-page":"3","article-title":"Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis","volume":"11","author":"Habibollahi","year":"2011","journal-title":"Hepat. Mon."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1749-6632.1993.tb35930.x","article-title":"Immunity to halothane metabolite-modified proteins in halothane hepatitis","volume":"685","author":"Kenna","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/hep.27253","article-title":"Halothane-induced hepatitis: Paradigm or paradox for drug-induced liver injury","volume":"60","author":"Kurth","year":"2014","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1002\/hep.1840080627","article-title":"Evidence for expression in human liver of halothane-induced neoantigens recognized by antibodies in sera from patients with halothane hepatitis","volume":"8","author":"Kenna","year":"1988","journal-title":"Hepatology"},{"key":"ref_60","first-page":"788","article-title":"Factors affecting the expression of trifluoroacetylated liver microsomal protein neoantigens in rats treated with halothane","volume":"18","author":"Kenna","year":"1990","journal-title":"Drug Metab. Dispos."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.det.2016.11.006","article-title":"Chemical-Induced Vitiligo","volume":"35","author":"Harris","year":"2017","journal-title":"Dermatol. Clin."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jdermsci.2015.02.001","article-title":"Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma","volume":"77","author":"Tokura","year":"2015","journal-title":"J. Dermatol. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Ito, S., and Wakamatsu, K. (2018). Biochemical Mechanism of Rhododendrol-Induced Leukoderma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020552"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/jid.2011.16","article-title":"Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy","volume":"131","author":"Picavet","year":"2011","journal-title":"J. Investig. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bcp.2012.06.015","article-title":"Mechanism of putative neo-antigen formation from N-propionyl-4-S-cysteaminylphenol, a tyrosinase substrate, in melanoma models","volume":"84","author":"Ito","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0625.2010.01200.x","article-title":"The haptenation theory of vitiligo and melanoma rejection: A close-up","volume":"20","author":"Westerhof","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Gu, L., Zeng, H., Takahashi, T., and Maeda, K. (2017). In vitro methods for predicting chemical leukoderma caused by quasi-drug cosmetics. Cosmetics, 4.","DOI":"10.3390\/cosmetics4030031"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jdermsci.2018.06.007","article-title":"Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma","volume":"91","author":"Gabe","year":"2018","journal-title":"J. Dermatol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Katahira, Y., Sakamoto, E., Watanabe, A., Furusaka, Y., Inoue, S., Hasegawa, H., Mizoguchi, I., Yo, K., Yamaji, F., and Toyoda, A. (2022). Upregulation of CD86 and IL-12 by rhododendrol in THP-1 cells cocultured with melanocytes through ROS and ATP. J Dermatol Sci.","DOI":"10.1016\/j.jdermsci.2022.12.012"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000441217","article-title":"T-Cell Responses to Tyrosinase-Derived Self-Peptides in Patients with Leukoderma Induced by Rhododendrol: Implications for Immunotherapy Targeting Melanoma","volume":"232","author":"Takagi","year":"2016","journal-title":"Dermatology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1038\/s41467-018-05566-x","article-title":"Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity","volume":"9","author":"Schrand","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0750-7658(05)81033-0","article-title":"Hapten inhibition of dextran anaphylaxis. Nine years of post-marketing surveillance of dextran 1","volume":"12","author":"Ljungstrom","year":"1993","journal-title":"Ann. Fran\u00e7aises D\u2019anesth\u00e9sie R\u00e9animation"},{"key":"ref_73","first-page":"429","article-title":"Allergic reactions to colloid fluids in anesthesia","volume":"32","author":"Hanzek","year":"2020","journal-title":"Psychiatr. Danub."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jaci.2008.04.032","article-title":"Epidemiologic risks for food allergy","volume":"121","author":"Lack","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.14573\/altex.2013.4.473","article-title":"From pathways to people: Applying the adverse outcome pathway (AOP) for skin sensitization to risk assessment","volume":"30","author":"MacKay","year":"2013","journal-title":"ALTEX"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/aivt.2017.0010","article-title":"An Adverse Outcome Pathway for Sensitization of the Respiratory Tract by Low-Molecular-Weight Chemicals: Building Evidence to Support the Utility of In Vitro and In Silico Methods in a Regulatory Context","volume":"3","author":"Sullivan","year":"2017","journal-title":"Appl. Vitr. Toxicol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1039\/c7tx00272f","article-title":"Skin and respiratory chemical allergy: Confluence and divergence in a hybrid adverse outcome pathway","volume":"7","author":"Kimber","year":"2018","journal-title":"Toxicol. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1039\/C7TX00058H","article-title":"Application of proteomics in the elucidation of chemical-mediated allergic contact dermatitis","volume":"6","author":"Hoper","year":"2017","journal-title":"Toxicol. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.smim.2003.08.007","article-title":"Chemokine regulation of naive T cell traffic in health and disease","volume":"15","author":"Weninger","year":"2003","journal-title":"Semin. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","article-title":"Complexities of CD28\/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation","volume":"19","author":"Salomon","year":"2001","journal-title":"Ann. Rev. Immunol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000411607","article-title":"Guinea pig maximization test","volume":"14","author":"Wahlberg","year":"1985","journal-title":"Curr. Probl. Dermatol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0300-483X(90)90012-6","article-title":"A review of the Buehler guinea pig skin sensitization test and its use in a risk assessment process for human skin sensitization","volume":"61","author":"Robinson","year":"1990","journal-title":"Toxicology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0300-483X(94)90193-7","article-title":"The local lymph node assay: Developments and applications","volume":"93","author":"Kimber","year":"1994","journal-title":"Toxicology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1600-0536.2002.470601.x","article-title":"The local lymph node assay: Past, present and future","volume":"47","author":"Kimber","year":"2002","journal-title":"Contact Dermat."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Tornqvist, E., Annas, A., Granath, B., Jalkesten, E., Cotgreave, I., and Oberg, M. (2014). Strategic focus on 3R principles reveals major reductions in the use of animals in pharmaceutical toxicity testing. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101638"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/toxsci\/kfh213","article-title":"Development of a peptide reactivity assay for screening contact allergens","volume":"81","author":"Gerberick","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/026119291604400513","article-title":"Nrf2 activation as a key event triggered by skin sensitisers: The development of the stable KeratinoSens reporter gene assay","volume":"44","author":"Natsch","year":"2016","journal-title":"Altern. Lab. Anim."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.tiv.2005.10.012","article-title":"Development of an in vitro skin sensitization test using human cell lines: The human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol","volume":"20","author":"Ashikaga","year":"2006","journal-title":"Toxicol. Vitr."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.tiv.2015.07.006","article-title":"Optimization of the IL-8 Luc assay as an in vitro test for skin sensitization","volume":"29","author":"Kimura","year":"2015","journal-title":"Toxicol. Vitr."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Forreryd, A., Gradin, R., Humfrey, C., Sweet, L., and Johansson, H. (2022). Exploration of the GARDskin applicability domain: Indirectly acting haptens, hydrophobic substances and UVCBs. ALTEX.","DOI":"10.14573\/altex.2201281"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"18904","DOI":"10.1038\/s41598-021-98247-7","article-title":"Quantitative assessment of sensitizing potency using a dose-response adaptation of GARDskin","volume":"11","author":"Gradin","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_92","unstructured":"OECD (2018). Test No. 442E: In Vitro Skin Sensitisation: In Vitro Skin Sensitisation assays addressing the Key Event on activation of dendritic cells on the Adverse Outcome Pathway for Skin Sensitisation. OECD Guidel. Test. Chem., 4, 21."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1615\/CritRevImmunol.v37.i2-6.60","article-title":"Accessory Molecule and Costimulation Requirements for CD4 T Cell Response","volume":"37","author":"Croft","year":"2017","journal-title":"Crit. Rev. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0887-2333(02)00060-7","article-title":"Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers","volume":"16","author":"Ashikaga","year":"2002","journal-title":"Toxicol. Vitr."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Sebastiao, A.I., Ferreira, I., Brites, G., Silva, A., Neves, B.M., and Teresa Cruz, M. (2020). NLRP3 Inflammasome and Allergic Contact Dermatitis: A Connection to Demystify. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090867"},{"key":"ref_96","unstructured":"OECD (2016). OECD Guidance Document on the Reporting of Defined Approaches and Individual Information Sources to Be Used within Integrated Approaches to Testing and Assessment (IATA) for Skin Sensitization, Organisation for Economic Cooperation and Development."},{"key":"ref_97","first-page":"613","article-title":"The HaCaT\/THP-1 Cocultured Activation Test (COCAT) for skin sensitization: A study of intra-lab reproducibility and predictivity","volume":"36","author":"Eskes","year":"2019","journal-title":"ALTEX"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tox.2010.12.004","article-title":"Use of the human monocytic leukemia THP-1 cell line and co-incubation with microsomes to identify and differentiate hapten and prohapten sensitizers","volume":"280","author":"Chipinda","year":"2011","journal-title":"Toxicology"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1248\/bpb.25.351","article-title":"NADPH-oxidase may contribute to IL-12 production in macrophages stimulated with CpG phosphorothioate oligodeoxynucleotides","volume":"25","author":"Aramaki","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Ichikawa, S., Miyake, M., Fujii, R., and Konishi, Y. (2012). MyD88 associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035880"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.4049\/jimmunol.165.8.4704","article-title":"Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells","volume":"165","author":"Schnurr","year":"2000","journal-title":"J. Immunol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s12272-014-0502-6","article-title":"HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics","volume":"38","author":"Choi","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0016-5085(89)80072-1","article-title":"Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability","volume":"96","author":"Hidalgo","year":"1989","journal-title":"Gastroenterology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","article-title":"Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells","volume":"79","author":"Artursson","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Verhoeckx, K., Cotter, P., Lopez-Exposito, I., Kleiveland, C., Lea, T., Mackie, A., Requena, T., Swiatecka, D., and Wichers, H. (2015). Caco-2 Cell Line. The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models, Springer.","DOI":"10.1007\/978-3-319-16104-4"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMra1301758","article-title":"Occupational asthma","volume":"370","author":"Tarlo","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.yrtph.2016.06.006","article-title":"Developing a framework for assessing chemical respiratory sensitization: A workshop report","volume":"80","author":"North","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2015.01.038","article-title":"History of interleukin-4","volume":"75","author":"Paul","year":"2015","journal-title":"Cytokine"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","article-title":"T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production","volume":"75","author":"Zhu","year":"2015","journal-title":"Cytokine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3389\/fimmu.2017.00929","article-title":"Prediction of Chemical Respiratory and Contact Sensitizers by OX40L Expression in Dendritic Cells Using a Novel 3D Coculture System","volume":"8","author":"Mizoguchi","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1084\/jem.20051135","article-title":"TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand","volume":"202","author":"Ito","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Furue, M., and Furue, M. (2021). OX40L-OX40 Signaling in Atopic Dermatitis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122578"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.humimm.2013.05.017","article-title":"Generation of a large number of functional dendritic cells from human monocytes expanded by forced expression of cMYC plus BMI1","volume":"74","author":"Haruta","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Mizoguchi, I., Katahira, Y., Inoue, S., Sakamoto, E., Watanabe, A., Furusaka, Y., Irie, A., Senju, S., Nishimura, Y., and Mizukami, S. (2022). A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells. ALTEX.","DOI":"10.14573\/altex.2111181"},{"key":"ref_116","first-page":"179","article-title":"State-of-the-art and new options to assess T cell activation by skin sensitizers: Cosmetics Europe Workshop","volume":"35","author":"Kuhnl","year":"2018","journal-title":"ALTEX"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.yrtph.2014.02.008","article-title":"The T-cell-dependent antibody response assay in nonclinical studies of pharmaceuticals and chemicals: Study design, data analysis, interpretation","volume":"69","author":"Lebrec","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/15476910701337357","article-title":"Primary immune response to sheep red blood cells (SRBC) as the conventional T-cell dependent antibody response (TDAR) test","volume":"4","author":"Ladics","year":"2007","journal-title":"J. Immunotoxicol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4939-8549-4_6","article-title":"The Sheep Erythrocyte T-Dependent Antibody Response (TDAR)","volume":"1803","author":"Ladics","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.96.1.185","article-title":"A two-step, two-signal model for the primary activation of precursor helper T cells","volume":"96","author":"Bretscher","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","article-title":"Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation","volume":"8","author":"Wieczorek","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1615\/CritRevImmunol.v18.i5.10","article-title":"CD28\/B7 costimulation: A review","volume":"18","author":"Greenfield","year":"1998","journal-title":"Crit. Rev. Immunol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"ref_125","first-page":"137","article-title":"T cell responses to drugs and drug metabolites","volume":"104","author":"Earnshaw","year":"2014","journal-title":"Exp. Suppl."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0000000000000458","article-title":"Mechanisms leading to T-cell activation in drug hypersensitivity","volume":"18","author":"Meng","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e2000267","DOI":"10.1002\/pmic.202000267","article-title":"Drug hapten-specific T-cell activation: Current status and unanswered questions","volume":"21","author":"Adair","year":"2021","journal-title":"Proteomics"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"653102","DOI":"10.3389\/fimmu.2021.653102","article-title":"Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire?","volume":"12","author":"Bechara","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1016730","DOI":"10.3389\/fimmu.2022.1016730","article-title":"Hypersensitivity reactions to small molecule drugs","volume":"13","author":"Han","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: The p-i concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000441280","article-title":"Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors","volume":"168","author":"Pichler","year":"2015","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/all.14962","article-title":"The important role of non-covalent drug-protein interactions in drug hypersensitivity reactions","volume":"77","author":"Pichler","year":"2022","journal-title":"Allergy"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bmj.299.6710.1259","article-title":"Hay fever, hygiene, and household size","volume":"299","author":"Strachan","year":"1989","journal-title":"BMJ"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.it.2008.11.006","article-title":"Does hapten exposure predispose to atopic disease? The hapten-atopy hypothesis","volume":"30","author":"McFadden","year":"2009","journal-title":"Trends Immunol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2222.2010.03684.x","article-title":"The Hapten-Atopy hypothesis II: The \u2018cutaneous hapten paradox\u2019","volume":"41","author":"McFadden","year":"2011","journal-title":"Clin. Exp. Allergy"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/1\/123\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:04:36Z","timestamp":1760119476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/1\/123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":137,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["biology12010123"],"URL":"https:\/\/doi.org\/10.3390\/biology12010123","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}